Watson Biotech announced that the company previously disclosed that it plans to issue shares to specific targets in 2026. On August 27, 2026, it received a notice from the Shenzhen Stock Exchange. The application documents are complete and accepted; the offering still needs to be reviewed by the Shenzhen Stock Exchange and approved for registration by the China Securities Regulatory Commission before it can be implemented.

Watson Biotech announced that the company previously disclosed that it plans to issue shares to specific targets in 2026. On August 27, 2026, it received a notice from the Shenzhen Stock Exchange. The application documents are complete and accepted; the offering still needs to be reviewed by the Shenzhen Stock Exchange and approved for registration by the China Securities Regulatory Commission before it can be implemented.